ShareValue scores for PFIZER.NSE: Valuation 42, Quality 73, Growth 48, Health 56.

PFIZER.NSE
NSE

Pfizer Limited

₹4,900.00(-0.16%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 15%
Valuation
42
Fair Value
Price vs Value
Quality
73
Strong
Business Strength
Growth
48
Moderate
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
27
Bearish
Price Trend

Company Details

About

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026